Cooper Pharma, Morocco’s pharmaceutical plant has agreed to open a branch in Rwanda during agreements signed yesterday as Moroccan King Mohammed VI visited Rwanda.
The plant will produce most of the needed drugs in Rwanda and on international market.
During the agreements signing ceremony yesterday, Rwanda was represented by the CEO of Rwanda Development Board (RDB), Francis Gatare, while Morocco was represented by Jaouad Cheikh Lahlou, the executive director of Cooper Pharma and Othman Benjelloun, the director of Bank of Africa.
Serge Kamuhinda, the Chief Operating Officer of Rwanda Development Board (RDB), has said that the plant will play a vital role reducing supply and demand gaps.
“The coming of Cooper Pharma, as a manufacturing firm of drugs is in compliance with long term government goals of reducing the quantities of imports and increase exports,” he said.
Cooper Pharma was launched in 1933.
It is expected that Cooper Pharma will start operating in Rwanda in 2019. It will be built on 10 000 m2 in Kigali Special Economic Zone, Gasabo district.
- Jaouad Cheikh Lahlou, the executive director of Cooper Pharma and the CEO of Rwanda Development Board (RDB), Francis Gatare signing agreements yesterday.